Evidence map›Paper›PMID 33433784›Full record

ArticleInterdisciplinary sciences, computational life sciences2021

A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.

Talha Burak Alakus, Ibrahim Turkoglu

Open access · bronzeAbstract read
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Prediction of viral-host interactions of COVID-19 by computational methods.Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Talha Burak AlakusFaculty of Engineering, Department of Software Engineering, Kirklareli University, 39000, Kirklareli, Turkey. talhaburakalakus@klu.edu.tr.ORCID http://orcid.org/0000-0003-3136-3341
Ibrahim TurkogluFaculty of Technology, Department of Software Engineering, Firat University, 23119, Elazig, Turkey.
Fırat University · TRKırklareli University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new type of corona virus (SARS-COV-2) emerging in Wuhan, China has spread rapidly to the world and has become a pandemic. In addition to having a significant impact on daily life, it also shows its effect in different areas, including public health and economy. Currently, there is no vaccine or antiviral drug available to prevent the COVID-19 disease. Therefore, determination of protein interactions of new types of corona virus is vital in clinical studies, drug therapy, identification of preclinical compounds and protein functions. Protein-protein interactions are important to examine protein functions and pathways involved in various biological processes and to determine the cause and progression of diseases. Various high-throughput experimental methods have been used to identify protein-protein interactions in organisms, yet, there is still a huge gap in specifying all possible protein interactions in an organism. In addition, since the experimental methods used include cloning, labeling, affinity purification mass spectrometry, the processes take a long time. Determining these interactions with artificial intelligence-based methods rather than experimental approaches may help to identify protein functions faster. Thus, protein-protein interaction prediction using deep-learning algorithms has been employed in conjunction with experimental method to explore new protein interactions. However, to predict protein interactions with artificial intelligence techniques, protein sequences need to be mapped. There are various types and numbers of protein-mapping methods in the literature. In this study, we wanted to contribute to the literature by proposing a novel protein-mapping method based on the AVL tree. The proposed method was inspired by the fast search performance on the dictionary structure of AVL tree and was used to verify the protein interactions between SARS-COV-2 virus and human. First, protein sequences were mapped by both the proposed method and various protein-mapping methods. Then, the mapped protein sequences were normalized and classified by bidirectional recurrent neural networks. The performance of the proposed method was evaluated with accuracy, f1-score, precision, recall, and AUC scores. Our results indicated that our mapping method predicts the protein interactions between SARS-COV-2 virus proteins and human proteins at an accuracy of 97.76%, precision of 97.60%, recall of 98.33%, f1-score of 79.42%, and with AUC 89% in average.

Indexed as

Deep LearningAlgorithmsAmino AcidsCOVID-19Genome, ViralHumansProtein BindingProtein Interaction MappingReproducibility of ResultsROC CurveSARS-CoV-2Amino AcidsAVL treeCOVID-19Deep learningProtein mappingSARS-COV-2

Identifiers

PMID33433784
PMCPMC7801232
OpenAlexW3120634523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.